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. Podocytes have three structurally and functionally sis (FSGS); in children with congenital nephrotic syndrome different segments: the cell body, major processes, and of the Finnish type (CNF); and in normal kidney tissue. In foot processes [1] . Microtubules in the major processes particular, we examined whether an association exists between are connected to an actin-based contractile microfilasynaptopodin expression in podocyte cells and the response ment apparatus in the foot process that allows the podoto steroids in INS, and whether synaptopodin expression can predict FSGS upon the initial kidney biopsy in children who cytes to maintain and alter cell shape and perform slow progress from MCD or DMH to FSGS. and directed movements of the foot processes [1, 2] . The pressed exclusively in the foot process of podocytes in Results. Synaptopodin expression was absent in areas of the kidney and in the dendritic spines of the telencephalic sclerosis. In nonsclerosed glomeruli, synaptopodin was signifisynapses [3] . Synaptopodin is believed to modulate the cantly less expressed in all groups of INS and in CNF compared actin-based shape and motility of the podocyte foot procwith normal (P Ͻ 0.0001 for both L and A, in each MCD, esses [3] . It is present in only the completely differenti-DMH, FSGS, and CNF). In INS, synaptopodin expression decreased in order from MCD to DMH to FSGS, reaching statistiated podocyte, and its expression begins in the capillary cal significance between MCD and FSGS (P ϭ 0.001 for L and loop stage of glomerular development, at which time the P ϭ 0.05 for A). Greater synaptopodin expression in podocytes formation of foot processes also commences [4, 5] . While was associated with a significantly better response to steroid synaptopodin is expressed in the foot processes, Wilm's therapy (P Ͻ 0.05 for both L and A). On the other hand, tumor-1 (WT-1) protein is exclusively expressed in the Loss and disaggregation of the actin cytoskeleton precede these ultrastructural changes and onset of protein-uria [11, 12] . MCD is characterized by minimal changes CNF 9, and normal 7. The age at the time of biopsy was noted. Children with INS were divided into two groups in the glomerulus. It responds well to steroid treatment and rarely progresses to renal failure. On other hand, based on clinical response to steroid therapy. The standard definition for response to steroid in INS was used FSGS is characterized by segmental glomerular hyalinosis and sclerosis; it responds poorly to steroid treatment [14] . Children in group A (N ϭ 19) went into remission with steroid therapy with/without an eight-week course and frequently progresses to renal failure [13] . The clinical course of DMH lies between MCD and FSGS. MCD of cyclophosphamide. Eleven children had received steroids only, while eight had received in addition an eight-and DMH have been observed to progress to FSGS on subsequent kidney biopsies, suggesting that these lesions week course of cyclophosphamide. Children in group B (N ϭ 19) were either steroid resistant (N ϭ 12) or steroid lie on a continuum [14-17]. The initial therapy to all forms of INS is by steroids, to which the response can dependent (N ϭ 7) needing additional immunosuppressive therapy in different combinations, such as cyclophos-be diverse, and certain children may need additional immunosuppressive therapy to which they may or may not phamide (N ϭ 5), chlorambucil (N ϭ 5), cyclosporine (N ϭ 12), azathioprine (N ϭ 1), or FK 506 (N ϭ 1). No respond.
Congenital nephrotic syndrome of the Finnish type further subgrouping was done, as the lack of adequate numbers in various subgroups made statistical analysis (CNF) occurs from a genetic mutation in the nephrin protein, normally present in the slit diaphragm of the superfluous. An additional four children who had progressed from MCD or DMH to FSGS were analyzed foot processes [18, 19] . The disease is characterized by massive proteinuria starting very early in life, at times separately. Serial 3 m sections were obtained from the cases in utero [19, 20] . It does not respond to steroids and needs aggressive treatment, including continuous albumin infu-listed previously in this article and were air dried and heat fixed on slides. The sections were deparaffinized with sions, bilateral nephrectomy, and renal replacement therapy in infancy [20] .
xylene and iodine and were rehydrated in graded series of alcohol. The sections were treated with Target Re-A decrease or loss of synaptopodin expression was trieval Solution (Dako #S1700; Dako Corp., Carpinteria, previously observed in idiopathic FSGS, collapsing FSGS, CA, USA) in a steamer at 90 to 95ЊC for 20 minutes and and HIV-associated nephropathy [21] [22] [23] . On the other then cooled for 15 minutes. The endogenous avidin and hand, the expression was normal in MCD, mesangioprolbiotin activity was blocked by egg white and skimmed iferative glomerulonephritis, membranous nephropathy, milk as described by Miller et al [25] . The sections were and IgA nephropathy [21-23]. Barisoni et al concluded stained by immunohistochemistry on the automated that in collapsing FSGS, there is a dysregulation of the Dako Autostainer 3400 using Dako's LSAB ϩ immunopodocyte phenotype, which is characterized by lack of peroxidase kit with streptavidin conjugated to horseradsynaptopodin expression [21] . Based on these findings, ish peroxidase. Anti-synaptopodin, a mouse monoclonal we investigated for synaptopodin expression in INS, antibody (ARP Inc., Belmont, MA, USA) was used in 1:1 CNF, and normal children to examine whether it could dilution for synaptopodin staining. Anti-human WT-1, a be a key for differentiating among the various entities of mouse monoclonal antibody (Dako Corp.), was used in INS. We also looked for a possible association between 1:100 dilution for WT-1 staining. The staining for WT-1 synaptopodin expression in INS and response to steroids was performed for tissue quality control for fixation and and whether synaptopodin expression could predict processing of the archived tissue. Both positive and nega-FSGS on the initial biopsy in children who progress from tive controls for synaptopodin and WT-1 were run with MCD or DMH to FSGS. each run on the Dako Autostainer 3400. Diaminobenzidine was used as the chromogen.
METHODS
Kidney biopsies stained by immunohistochemistry for Kidney biopsies from children with INS were included WT-1 and synaptopodin were first examined by light in the study only if (1) the histology was consistent with microscopy. On light microscopy, WT-1 expression was MCD, DMH, or FSGS as described by the International scored from 0 to 2ϩ. The characteristics of synaptopodin Study of Kidney Disease in Children [24] ; (2) patients expression in each group were initially evaluated under had a minimum of two years of follow-up from the prilight microscopy and were then further analyzed by commary diagnosis of INS to ascertain the response to steroid puterized image analysis using Optimas software. Optitherapy; and (3) the tissue in the paraffin block had at mas is a standard image analysis program used for least five nonsclerosed glomeruli. Control tissue (norquantitative immunohistochemistry [26] [27] [28] . Synaptomal) from nephrectomy specimens from children with podin stands out as a distinct brown stain against the Wilm's tumor and kidney tissue from children with CNF light background of the remaining glomerulus. In each were included in the study as well. In all, 54 kidney biopsy, the five maximally stained nonsclerosed glomeruli were analyzed for both luminance and percentage biopsies were investigated: MCD 18, DMH 7, FSGS 13, Immunohistochemistry staining using diaminobenzidine as chromogen is shown (ϫ400). glomerular area of synaptopodin staining. Five glomeruli was similar to normals but was weaker in intensity, and are considered an adequate sample for diagnosis [29, 30] . like in normals, it was linear along the glomerular base-In each glomerulus, for luminance, an average gray value ment membrane; however, at times attenuated in thick-(GV) from 0 to 255 was obtained from 320 data points, ness with minimal segmental interruption and minimal with 0 being equivalent to black and 255 equivalent to granulation (Fig. 1B ). In FSGS, in nonsclerosed glomerwhite. The lower the luminance GV, the higher is the uli, synaptopodin expression was very weak with occaintensity of staining. The percentage glomerular area of sional glomeruli showing no expression, and the linear staining was calculated by drawing a region of interest expression changed to more segmental pattern with around the glomerulus and calculating the percentage marked interruption ("patchy") and coarse granulations of area stained with synaptopodin within the glomerulus (Fig. 1C ). In segmentally sclerosed glomerulus, the syat a fixed color threshold. For each biopsy, the average naptopodin expression was absent in areas of sclerosis for luminance GV and percentage glomerular area from and was patchy in the rest of the glomerulus. The pattern the five glomeruli was used. To compare luminance GV for DMH was in between MCD and FSGS. In CNF, the and percentage glomerular area among the five groups synaptopodin expression was extremely weak (Fig. 1D ). of MCD, DMH, FSGS, CNF, and normal children, uni-
The results of synaptopodin expression by quantitative variate analysis of variance (ANOVA) was used. Box computerized image analysis, for both luminance gray plots show the distribution of data in each group: the value and percentage glomerular area of staining in nonminimum, 25th percentile, 50th percentile, 75th percensclerosed glomeruli in the five groups, and the mean Ϯ tile, and maximum value. Two-tailed unpaired Student's SD for age are shown in Table 1 . Children with FSGS t test was used to compare groups A and B and mean were significantly older, and those with CNF were sigage among the study groups, and paired t test for analysis nificantly younger than controls. The distribution of data of the group, which progressed to FSGS. of synaptopodin expression in normal, MCD, DMH, FSGS, and CNF children is shown as box plots for lumi-RESULTS nance GV in Figure 2A and percentage glomerular area in Figure 2B . The results of univariate ANOVA of the On light microscopy, WT-1 and synaptopodin expresdata presented in Figure 2 are shown in Tables 2 and 3 , sion were absent in areas of sclerosis. In nonsclerosed respectively. Synaptopodin was significantly less expressed glomeruli, WT-1 expression was 2ϩ in all normal, MCD, in MCD, DMH, FSGS, and CNF children compared DMH, FSGS, and CNF tissue specimen. In normal chilwith normal (P Ͻ 0.0001 for both luminance and area). dren, the morphology of synaptopodin expression was Among the INS entities, synaptopodin expression deintense, linear along the glomerular basement membrane, creased in order for both luminance and percentage glothick with very minimal segmental interruption and minimerular area from MCD to DMH to FSGS, reaching mal granulation (that is, granular pattern in staining; Fig.  1A ). In MCD, the qualitative expression of synaptopodin statistical significance between MCD and FSGS (P ϭ The lower the luminance GV, the higher is the intensity of staining. The results are expressed as mean Ϯ SD. Abbreviations are: MCD, minimal change disease; DMH, diffuse mesangial hypercellularity; FSGS, focal segmental glomerulosclerosis; and CNF, congenital nephrotic syndrome of the Finnish type. glomerular area for synaptopodin expression in group A was 15.5% Ϯ 9.0% versus group B, 8.8% Ϯ 10.3% (P ϭ 0.039). In group A, the predominant diagnosis was MCD (N ϭ 14), and in group B, it was FSGS (N ϭ 12). 0.001 for luminance GV and P ϭ 0.05 for percentage
The sensitivity and specificity for synaptopodin expresglomerular area). sion and good steroid response at luminance GV of Ͻ140 The distribution of data in group A and B is shown as box plots in Figure 3 . The luminance GV for synapto-and percentage glomerular area of Ͼ12% were 68.4 and
DISCUSSION
Synaptopodin is a linear proline-rich protein that is intimately associated with actin microfilaments present in the foot processes of the podocytes. In a puromycin model of nephrotic syndrome, the actin cytoskeletal structure is disaggregated with onset of proteinuria and is completely restored on resolution of proteinuria [11, 12] . One would expect synaptopodin to be altered in INS because of its association with the actin cytoskeletal apparatus. We did observe a decrease in synaptopodin expression in INS with a decrease in order from MCD to DMH to FSGS. Barisoni et al reported loss of synaptopodin in collapsing FSGS and HIV nephropathy, but found no difference between normal and MCD [21]. Kemeny et al observed decrease in synaptopodin even in early stages of idiopathic FSGS but preserved in MCD [22] . In both studies, synaptopodin was reported as either absent or present, but no attempt was made to quantitate the expression [21, 22] . Indeed, in our study on light microscopy, the qualitative morphological appearance of synaptopodin in MCD was almost similar to that of normal ( Fig. 1) . However, the expression of synaptopodin was significantly different on quantitative computerized image analysis (Tables 1-3 and Fig. 2 ). It thus seems that the loss of synaptopodin expression is not an "all or none phenomenon," as suggested in earlier studies, but may vary quantitatively from one entity to another, as well as among children with the same histology ( Figs. 1 and 2) . In support of our observation of the importance of quantitative analysis was the finding of intermediate expression of synaptopodin in DMH biopsies, which has long been regarded histologically and 
(A) luminance gray value (GV) and (B) percentage of glomerular area
Indeed, the synaptopodin expression was between MCD in nonsclerosed glomeruli in group A (steroid Ϯ cyclophosphamide and FSGS (Table 1 ). Furthermore, our observation of responsive) and group B (steroid resistant or dependent requiring additional immunosuppressive therapy). Outliers are shown as small much attenuation of synaptopodin expression in FSGS circles. rather than complete disappearance is supported by the report by Kihara et al [23] . As in other studies, synaptopodin and WT-1, which are exclusively expressed in podocytes, were absent in areas of sclerosis following re-78.9%, respectively, and the positive predictive value placement of podocytes and other glomerular cells by and negative predictive value were 76.5 and 71.4%, rehyaline and fibrous tissue [21, 22] . spectively.
Could the observed difference in synaptopodin ex-In four children with progression from MCD or DMH pression between INS and normal children be age related to FSGS on successive biopsies, synaptopodin expression (Table 1) ? Although children with FSGS were older, was lower on final biopsy with FSGS (luminance GV, there was no significant difference between the ages of 163.0 Ϯ 17.1; percentage glomerular area, 3.0% Ϯ 4.8%) children with MCD or DMH and normal children. There compared with initial biopsy (luminance GV, 135.6 Ϯ was no correlation between luminance GV or percentage 14.9; percentage glomerular area, 13.4% Ϯ 8.6%); howglomerular area and age of the children (data not shown). ever, because of the small number of subjects, the differ-Furthermore, despite the difference in ages between chilence did not reach statistical significance. The results dren with FSGS and those with CNF, the expression of from the initial biopsy in the four children resembled synaptopodin in both groups was very similar (Table 1 the findings in other children with MCD and DMH and Fig. 2 ). There was no difference between Caucasian and African American children (data not shown). Hence, rather than FSGS. it seems unlikely that either age or race played a factor evaluate for any association between steroid response and synaptopodin expression. Unlike adults with INS, in the expression of synaptopodin.
Was the observed difference in synaptopodin expres-24-hour proteinuria quantitation is not performed on a routine basis in children with INS, and thus, we did not sion between INS and normal children the result of loss of podocytes from the glomerulus or possibly an artifact?
have the data on 24-hour proteinuria in all children at the time of biopsy to estimate a correlation between The loss of podocytes alone cannot explain the loss of synaptopodin expression in children with INS, as unlike proteinuria and synaptopodin expression. There was no difference between onset of nephrotic syndrome and children with inflammatory glomerulonephritis, loss of podocytes in the urine is not observed in children with timing of renal biopsy between the different groups (data not shown). Only four children in the described case series MCD [31] . Using double staining technique, Kemeny et al showed a decrease in synaptopodin expression in FSGS have either elevated creatinine or have progressed to end-stage renal failure, and therefore, we did not corre-without loss of podocytes [22] . Synaptopodin and WT-1 are exclusively expressed in podocytes, the former in the late synaptopodin expression and renal outcome as the sample size was too small to make any statistical analysis. foot processes and the latter in the nucleus. In our study, the WT-1 expression was abundant in all five categories,
Children with INS may progress from MCD or DMH to FSGS. It would be advantageous to have a marker suggesting that the loss of synaptopodin in INS was not the result of disappearance of podocytes. Therefore, we by which one could predict FSGS as early as the initial biopsy that still shows findings of MCD or DMH. In four do not believe that the observed loss of synaptopodin expression in INS could have been an artifact.
children who upon their renal biopsies progressed from MCD or DMH to FSGS, synaptopodin expression failed Minimal change disease and DMH have been shown to progress to FSGS, and the three entities are believed to predict FSGS on their initial biopsy, as its expression on those biopsies was closer to that observed in MCD to lie along a continuum [14] [15] [16] [17] . In most children, MCD responds well to steroid therapy and has a benign clinical rather than FSGS. The sample size was too small to reach a definite conclusion, and therefore, the predictive course, while FSGS responds poorly to steroid therapy and carries a guarded prognosis for chronic renal failure, accuracy of this method cannot be ruled out completely and needs to be investigated further. while DMH has a clinical course in between the two. Thus, on scale of severity, the severity in INS increases
As discussed previously in this article, the severity in INS increases in order from MCD to DMH to FSGS. In in order from MCD to DMH to FSGS. The treatment of all three entities starts with corticosteroids. Some chil-our study, we observed the following: (1) synaptopodin expression decreased significantly in order from normal dren have a good response to steroids or may need an additional short course of cyclophosphamide to enter to MCD to DMH to FSGS; (2) synaptopodin expression decreased significantly in order from normal to group A remission. They are also regarded to have a better prognosis (group A). In other children who do not respond to to group B; and (3) in children who progressed from MCD or DMH to FSGS, synaptopodin expression was the previously mentioned protocol, aggressive treatment with additional immunosuppressive drugs is required.
lower on final biopsy with FSGS compared with the initial biopsy. These findings cumulatively suggest that The prognosis in that group is more guarded (group B). We found that children in group A had better expression synaptopodin expression decreases with increasing severity of INS. The disease process in MCD, DMH, and of synaptopodin than those in group B (Fig. 3 ). Not surprisingly, group A was comprised mainly of MCD FSGS is believed to have an immunologic basis, which has still not been well elucidated. The characteristic and group B of FSGS children. However, in spite of the statistical significance between groups A and B, the data changes of INS are seen in the podocyte cell, and both albuminuria and FSGS can be produced in vivo by iso-could not well predict the steroid responsiveness for the individual patient. This could partially be explained by lated podocyte injury in experimental animals [32, 33] . The decrease in synaptopodin expression in podocytes the fact that biopsies of MCD were biased toward more severe cases of MCD, as children with MCD with imme-indirectly reflects the magnitude of damage suffered by the podocyte cell with increasing severity in INS. diate response to steroids do not undergo a biopsy. It is thus possible that the difference between groups A and To test the hypothesis of whether the alteration in synaptopodin expression is a generalized podocyte cell B would have been stronger if we had biopsy material from all children with MCD. The response to immuno-phenomenon and not necessarily related to an immunologic injury in INS or to immunosuppressive treatment, suppression treatment in INS lies along a continuum, and hence, it is difficult to categorize them clearly. The we evaluated synaptopodin expression in CNF, a nonimmune podocyte disease, which is due to mutation in the clinical relevance and statistical strength were lost on attempts to subgroup the data further, and thus, the nephrin protein and is not treated with immunosuppressive medications [18, 19] . We found synaptopodin ex-biopsies were grouped empirically into two groups, as discussed previously in this article. The purpose was to pression to be decreased also in CNF. Shih [35, 36] . We hypothesize that nephrin, CD2AP, the magnitude of damage. We conclude that synaptopathic Nephrotic Syndrome: A report of the Southwest Pediatric podin has a potential to be used as a marker to study Nephrology Study Group. Kidney Int 27: [442] [443] [444] [445] [446] [447] [448] [449] 1985 the alteration in podocyte cells and possibly to predict
